Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoru Meguro

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Clinical Genitourinary Cancer|May 20, 2026
CT-Measured Psoas Area Predicts Urinary Incontinence Trajectories and Persistence After Robotic Prostatectomy: A 12-Month Analysis Using the 1-Hour Pad TestAkihisa Hasegawa, Kenji Omae, Yuki Harigane, et al.
Cancer Medicine|November 14, 2024
A Novel Gene Expression Scoring System Predicts Recurrence in Non-Muscle-Invasive Bladder Cancer PatientsEmina Kayama, Motohide Uemura, Akifumi Onagi, et al.
Current Oncology (Toronto, Ont.)|August 27, 2025
Targeting Senescence in Oncology: An Emerging Therapeutic Avenue for CancerSatoru Meguro, Syunta Makabe, Kei Yaginuma, et al.
Cancer Science|February 23, 2021
Upregulation of glucocorticoid receptor-mediated glucose transporter 4 in enzalutamide-resistant prostate cancerSeiji Hoshi, Satoru Meguro, Hitomi Imai, et al.
Cancers|December 30, 2025
Immunosuppressive Role of Integrin β8 in Recurrence After Bacillus Calmette-Guérin (BCG) Therapy for Non-Muscle Invasive Bladder CancerSeiji Hoshi, Satoru Meguro, Syunta Makabe, et al.
BMC Urology|January 24, 2025
Longitudinal changes in factors affecting postoperative patient satisfaction after robot-assisted radical prostatectomy: an assessment using a patient-reported questionnaireSoichiro Ogawa, Kei Yaginuma, Yuki Harigane, et al.
In Vivo (Athens, Greece)|September 13, 2022
Low Risk of Venous Thromboembolism After Robot-assisted Radical Prostatectomy Through Systemic Image Assessment: A Prospective StudySatoru Meguro, Masao Kataoka, Y U Endo, et al.
Nature Aging|September 9, 2024
Preexisting senescent fibroblasts in the aged bladder create a tumor-permissive niche through CXCL12 secretionSatoru Meguro, Yoshikazu Johmura, Teh-Wei Wang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 11, 2024
Novel astatine (<sup>211</sup>At)-labelled prostate-specific membrane antigen ligand with a neopentyl-glycol structure: evaluation of stability, efficacy, and safety using a prostate cancer xenograft modelKei Yaginuma, Kazuhiro Takahashi, Seiji Hoshi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 20, 2026
Efficacy and Safety of Enzalutamide and Abiraterone in CRPC Patients With a History of Other Cancers: A Sub-Analysis of the ENABLE Study for PCaSeiji Hoshi, Kouji Izumi, Satoru Meguro, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Clinical Genitourinary Cancer|May 20, 2026
CT-Measured Psoas Area Predicts Urinary Incontinence Trajectories and Persistence After Robotic Prostatectomy: A 12-Month Analysis Using the 1-Hour Pad TestAkihisa Hasegawa, Kenji Omae, Yuki Harigane, et al.
Cancer Medicine|November 14, 2024
A Novel Gene Expression Scoring System Predicts Recurrence in Non-Muscle-Invasive Bladder Cancer PatientsEmina Kayama, Motohide Uemura, Akifumi Onagi, et al.
Current Oncology (Toronto, Ont.)|August 27, 2025
Targeting Senescence in Oncology: An Emerging Therapeutic Avenue for CancerSatoru Meguro, Syunta Makabe, Kei Yaginuma, et al.
Cancer Science|February 23, 2021
Upregulation of glucocorticoid receptor-mediated glucose transporter 4 in enzalutamide-resistant prostate cancerSeiji Hoshi, Satoru Meguro, Hitomi Imai, et al.
Cancers|December 30, 2025
Immunosuppressive Role of Integrin β8 in Recurrence After Bacillus Calmette-Guérin (BCG) Therapy for Non-Muscle Invasive Bladder CancerSeiji Hoshi, Satoru Meguro, Syunta Makabe, et al.
BMC Urology|January 24, 2025
Longitudinal changes in factors affecting postoperative patient satisfaction after robot-assisted radical prostatectomy: an assessment using a patient-reported questionnaireSoichiro Ogawa, Kei Yaginuma, Yuki Harigane, et al.
In Vivo (Athens, Greece)|September 13, 2022
Low Risk of Venous Thromboembolism After Robot-assisted Radical Prostatectomy Through Systemic Image Assessment: A Prospective StudySatoru Meguro, Masao Kataoka, Y U Endo, et al.
Nature Aging|September 9, 2024
Preexisting senescent fibroblasts in the aged bladder create a tumor-permissive niche through CXCL12 secretionSatoru Meguro, Yoshikazu Johmura, Teh-Wei Wang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 11, 2024
Novel astatine (<sup>211</sup>At)-labelled prostate-specific membrane antigen ligand with a neopentyl-glycol structure: evaluation of stability, efficacy, and safety using a prostate cancer xenograft modelKei Yaginuma, Kazuhiro Takahashi, Seiji Hoshi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 20, 2026
Efficacy and Safety of Enzalutamide and Abiraterone in CRPC Patients With a History of Other Cancers: A Sub-Analysis of the ENABLE Study for PCaSeiji Hoshi, Kouji Izumi, Satoru Meguro, et al.
Pageof 4